BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5457915)

  • 1. [Preliminary studies of the evaluation of immunodepressive activity in L1210 leukemia allografts in mice].
    Brambilla G; Cavanna M; Caraceni CE; Parodi S
    Boll Soc Ital Biol Sper; 1970 Mar; 46(5):230-3. PubMed ID: 5457915
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigenic changes of L1210 leukemia in mice treated with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide.
    Bonmassar E; Bonmassar A; Vadlamudi S; Goldin A
    Cancer Res; 1972 Jul; 32(7):1446-50. PubMed ID: 4402275
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of age and experimentally-induced disease on the tolerance of cytostatically-active materials in mice.
    Lemmel EM; Motycka K; Soucek J; Nouza K
    Arzneimittelforschung; 1967 Feb; 17(2):142-5. PubMed ID: 4173310
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental evaluation of potential anticancer agents XV. On the relative rates of growth and host kill of "single" leukemia cells that survive in vivo cytoxan therapy.
    Wilcox WS; Schabel FM; Skipper HE
    Cancer Res; 1966 May; 26(5):1009-14. PubMed ID: 5934786
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunosuppressive action in mice of diazoacetylglycine amide and diazoacetylglycine hydrazide in compairison to methotrexate].
    Baldini L; Brambilla G; Cavanna M; Parodi S
    Boll Soc Ital Biol Sper; 1968 Mar; 44(5):441-3. PubMed ID: 5674631
    [No Abstract]   [Full Text] [Related]  

  • 6. The immunodepressive activity of N-diazoacetylglycine derivatives in mice.
    Brambilla G; Cavanna M; Maura A; Parodi S; Furlani A; Scarcia V; Della Loggia R
    Arzneimittelforschung; 1973 May; 23(5):690-3. PubMed ID: 4145646
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological immunosuppressive agents.
    Salaman JR
    Ulster Med J; 1981; 50(Suppl 1):36-42. PubMed ID: 7015656
    [No Abstract]   [Full Text] [Related]  

  • 8. Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression.
    Schwartz HS; Grindey GB
    Cancer Res; 1973 Aug; 33(8):1837-44. PubMed ID: 4720795
    [No Abstract]   [Full Text] [Related]  

  • 9. The immunodepressive activity of N-diazoacetylglycine amide in some transplantation systems.
    Brambilla G; Parodi S; Cavanna M; Baldini L
    Transplantation; 1970 Jul; 10(1):100-5. PubMed ID: 4912983
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of alkylating agents on meningeal leukemia L1210 arising in methotrexate-treated mice.
    Chirigos MA; Humphreys SR
    Cancer Res; 1966 Aug; 26(8):1673-7. PubMed ID: 5923165
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of toxicity, immunodepressive and tolerogenic activity of thiamiprine, azathioprine and cyclophosphane].
    Filitis LN; Sorkina IuA; Pershin GN; Pevnitskiĭ LA; Solov'ev VV
    Farmakol Toksikol; 1971; 34(6):708-13. PubMed ID: 5139795
    [No Abstract]   [Full Text] [Related]  

  • 12. The immunodepressive activity of Escherichia coli L-asparaginase in some transplantation systems.
    Brambilla G; Parodi S; Cavanna M; Caraceni CE; Baldini L
    Cancer Res; 1970 Nov; 30(11):2665-70. PubMed ID: 4395089
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cyclophosphamide dose, antileukemic action and immuno-inhibitor effect].
    Mathé G; Schneider M; Schwarzenberg L
    Rev Fr Etud Clin Biol; 1968; 13(7):695-6. PubMed ID: 4882148
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of antineoplastic and immunosuppressive properties of ftorafur].
    Nosova TA; Babichev VA; Uteshev BS
    Farmakol Toksikol; 1976; 39(5):589-93. PubMed ID: 800767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of benzylpenicillin and doxycycline on toxicity and antineoplastic action of cyclophosphamide and methotrexate in mice].
    Pakulska W
    Acta Pol Pharm; 1992; 49(1-2):35-40. PubMed ID: 8769079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1973 Jun; 33(6):1290-4. PubMed ID: 4718678
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 2. Pharmacological characterization of 2-alkylsulfonyl-oxyalkylamino-oxazaphosphorine-2-oxides including immunological reaction].
    Arzneimittelforschung; 1974 Aug; 24(8):1149-60. PubMed ID: 4371545
    [No Abstract]   [Full Text] [Related]  

  • 18. Myeloablative and immunosuppressive properties of treosulfan in mice.
    Sjöö F; Hassan Z; Abedi-Valugerdi M; Griskevicius L; Nilsson C; Remberger M; Aschan J; Concha H; Gaughan U; Hassan M
    Exp Hematol; 2006 Jan; 34(1):115-21. PubMed ID: 16413398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression and experimental tuberculosis. I. The effects of immunosuppressive agents, antilymphocyte serum and antimacrophage serum on the survival of animals with subacute experimental tuberculosis.
    Müllerová M; Nouza K; Trnka L
    Biomedicine; 1973 Mar; 19(3):87-9. PubMed ID: 4734093
    [No Abstract]   [Full Text] [Related]  

  • 20. Leukemia L 1210 homograft in Swiss mice: immunologic, cellular and chemotherapeutic responses.
    Prince HN; Grunberg E
    J Immunol; 1969 Aug; 103(2):324-33. PubMed ID: 5803789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.